My Profile
Edit Profile
My Follows
My Wires
My Drafts
Analytics
Email Preferences
Sign Out
home
Latest
Shares
ETFs
Retirement
Markets
Buy Hold Sell
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Contributors
Find Funds
Newsletter
About Livewire
Advertising
Careers
Contact Us
Write a Wire
Notifications
Loading...
Write a wire
Account
My profile
My follows
My wires
My drafts
Analytics
Email preferences
Company
About Livewire
Advertising
Contact us
Sign out
Sign In
Join Free
Latest
Shares
ETFs
Retirement
Markets
Buy Hold Sell
Find funds
Newsletter
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Markets
Property
Weekend Report
Find Funds
Contributors
Newsletter
About Livewire
Advertising
Careers
Contact Us
Market Wraps
drug discovery
Latest news and analysis on drug discovery
Equities
May 12, 2026 14:27
Royalty pharma – funding the next generation of medicines
Royalty Pharma, a PM Capital holding, is reshaping how breakthrough medicines are funded and developed. By Alex Warnaar, PM Capital
PM Capital
PM Capital
May 12, 2026 14:27
Views from the Top
November 08, 2024 06:00
Bianca Ogden: This is a new biotech
boom
Platinum Asset Management's biotech specialist Dr Bianca Ogden outlines the major opportunities she is seeing in the sector.
Ally Selby
Livewire Markets
November 08, 2024 06:00
2
most
popular
Growth
7 steady ASX compounders with fundies’ tick of approval
Vishal Teckchandani,
Livewire Markets
Retirement
Betashares vs VanEck: The battle to build the ultimate 5-ETF super portfolio
Vishal Teckchandani,
Livewire Markets
Shares
The ASX stock UBS thinks could almost double, plus 8 more top picks
Keith Ford,
Livewire Markets
Growth
Auscap sees a “fantastic decade” for active as it backs 6 ASX stocks poised for a snapback
Vishal Teckchandani,
Livewire Markets
view all
Advertisement